Skip to main content
. 2020 Oct 27;10:587666. doi: 10.3389/fonc.2020.587666

Figure 3.

Figure 3

Overall survival in patients with incident biliary tract cancer in ever users and never users of metformin in the unmatched cohort (A) and the matched cohort (B). HR, hazard ratio; CI, confidence interval.

HHS Vulnerability Disclosure